The partnership will strengthen Masco Group by combining its leadership in clean utilities and process technologies with KeyPlants’ expertise and innovative energy in prefabricated, modular facility solutions
Masco Group, global provider of technological solutions for the pharmaceutical and biotech industries, has acquired a majority stake in Swedish company KeyPlants. The move will strengthen Masco’s leadership in engineering technologies for life sciences.
KeyPlants is a leading international industry partner for standardised as well as customised process-integrated modular prefabricated facility solutions. Based in Stockholm, the company has a fully integrated supply chain with more than 45 years of experience in project engineering, production and delivery, and has supplied more than 3,500 high-specification modules to at least 30 countries.
The partnership will strengthen Masco Group by combining its leadership in clean utilities and process technologies with KeyPlants’ expertise and innovative energy in prefabricated, modular facility solutions. It will support stronger value propositions for global supply chain challenges such as flexibility, reliability and fast-track manufacturing timelines to a global customer base of biopharmaceutical manufacturers and CDMOs focused on biologics, pharma and advanced therapy medicinal products (ATMPs), such as cell and gene therapies.
“We are happy to partner with KeyPlants, as it will expand our capabilities, service and product offerings, and evolve our manufacturing capacity,” says Luca Borella, CEO, Masco Group. “We look forward to working with them to further accelerate the global adoption of their innovative fast-track facility solutions, which are an essential aspect in the life science industry.”
He adds, “The companies share similar values, notably the commitment to teamwork, sustainability and customer care. Innovation is also an important synergetic element.”
“KeyPlants’ management and team are fully committed to this partnership with Masco Group,” says Jörgen Harrysson, MD and Board Member of KeyPlants AB. “Its global presence and network enable KeyPlants to continue with our strategy to serve existing and new clients with our fast-track solutions, including customised facilities as well as standardised PODs. We are also thrilled to be able to expand our presence and offerings in North America, Europe and Africa.”
“We see KeyPlants and Masco Group as a perfect fit, and we are excited at the prospect of making KeyPlants and its skilled teams an integral part of the growth trajectory of the Masco Group family,” comments Frans K A. Maas, Masco Group Board Member. “Masco Group is part of RSBG SE, a German-based long-term industrial partner of successful medium-sized companies, pursuing a buy-and-build strategy and focusing on competencies and areas which are of great importance during global transformations. This acquisition supports the vision to become a technology-leading turnkey provider, in particular in the growing and demanding markets of biologics, vaccines and ATMPs.”
